Stay updated on Nivolumab & Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-25T17:14:54.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-03-18T14:32:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-11T07:52:49.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-04T03:59:19.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has been updated with new dates and details regarding a clinical study involving Nivolumab and Lenalidomide for treating relapsed or refractory Non-Hodgkin and Hodgkin lymphoma, including a new last update date and changes to estimated timelines.
    Difference
    3%
    Check dated 2025-02-24T23:01:36.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-02-17T19:18:23.000Z thumbnail image

Stay in the know with updates to Nivolumab & Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page.